Literature DB >> 4315995

Platelet aggregation test with measles antigen in multiple sclerosis.

M Panelius, G Myllylä, K Penttinen, P Halonen, U K Rinne.   

Abstract

With the measles platelet aggregation test, a new technique recently developed for measuring virus antibody, 153 serum specimens from patients with multiple sclerosis and 164 controls were tested. With one of the three measles antigens used in the test a significantly higher positive rate (P<0.001) was obtained in the specimens from the patients with multiple sclerosis (40%) than in those from the controls (11%). The other two measles antigens also yielded slightly but not significantly higher positive rates in the patients with multiple sclerosis.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4315995      PMCID: PMC1700468          DOI: 10.1136/bmj.2.5707.461

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  19 in total

1.  Virus antibody levels in multiple sclerosis.

Authors:  C A Ross; J A Lenman; I D Melville
Journal:  Br Med J       Date:  1969-08-30

2.  [Measles antibodies in the serum of patients with multiple slcerosis].

Authors:  M Just; H P Rieder; G Ritzel
Journal:  Klin Wochenschr       Date:  1967-07-15

3.  Subacute sclerosing panencephalitis: structures resembling myxovirus nucleocapsids in cells cultured from brain.

Authors:  M Katz; S Oyanagi; H Koprowski
Journal:  Nature       Date:  1969-05-31       Impact factor: 49.962

4.  Subacute sclerosing panencephalitis: isolation of measles virus from a brain biopsy.

Authors:  L Horta-Barbosa; D A Fuccillo; J L Sever; W Zeman
Journal:  Nature       Date:  1969-03-08       Impact factor: 49.962

5.  Interaction in human blood platelets, viruses and antibodies. I. Platelet aggregation test with microequipment.

Authors:  K Penttinen; G Myllylä
Journal:  Ann Med Exp Biol Fenn       Date:  1968

6.  Interaction between human blood platelets, viruses and antibodies. IV. Post-Rubella thrombocytopenic purpura and platelet aggregation by Rubella antigen-antibody interaction.

Authors:  G Myllylä; A Vaheri; T Vesikari; K Penttinen
Journal:  Clin Exp Immunol       Date:  1969-03       Impact factor: 4.330

7.  Viral antibody in the cerebrospinal fluid and serum of multiple sclerosis patients.

Authors:  J K Clarke; D S Dane; G W Dick
Journal:  Brain       Date:  1965-12       Impact factor: 13.501

8.  Measles antibodies in patients with multiple sclerosis.

Authors:  J M Adams
Journal:  Neurology       Date:  1967-07       Impact factor: 9.910

9.  Subacute sclerosing panencephalitis: propagation of measles virus from brain biopsy in tissue culture.

Authors:  T T Chen; I Watanabe; W Zeman; J Mealey
Journal:  Science       Date:  1969-03-14       Impact factor: 47.728

10.  Defectiveness of interferon production and of rubella virus interference in a line of African green monkey kidney cells (Vero).

Authors:  J Desmyter; J L Melnick; W E Rawls
Journal:  J Virol       Date:  1968-10       Impact factor: 5.103

View more
  3 in total

1.  Differences in antibody responses in varicella, herpes zoster and after vaccination.

Authors:  T Kimoto; T Kurimura
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574

Review 2.  The possible viral aetiology of disseminated sclerosis.

Authors:  F Cathala; P Brown
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1972

3.  Measles antibodies detected by platelet aggregation and gel precipitation in patients with subacute sclerosing panencephalitis.

Authors:  T Palosuo; A A Salmi; O Pettay
Journal:  Arch Gesamte Virusforsch       Date:  1971
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.